Nitrogen
Medical Gases
- Drug class
- Medical Gases
- Availability
- Prescription only
- Routes
- Respiratory (Inhalation), Topical, Inhalation
- Markets covered
- 2
- Products on record
- 22
- FDA reports (12 mo)
- 5
Overview
Nitrogen is an active pharmaceutical ingredient in the Medical Gases group (V03AN). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 15 | April 28, 2026 |
| CA Canada | Health Canada | 7 | March 22, 2025 |
USUnited States· FDA
15 products
15 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Most-reported reactions to the US regulator (12 mo to June 4, 2026): 5 reports total. [3]
- Acetabulum Fracture 1
- Acne Cystic 1
- Anaphylactic Shock 1
- Coma 1
- Constipation 1
- Disease Recurrence 1
- Diverticulitis 1
- Drug Dependence 1
- Femur Fracture 1
- Groin Pain 1
- Hallucination, Visual
CACanada· Health Canada
7 products
7 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]FDA DailyMed · 0268620b-4e8b-4b… · revised November 26, 2025 [PDF]
- [2]Health Canada (DPD) · 00572829 · revised March 22, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.